Development of a prognostic model based on lysosome-related genes for ovarian cancer: insights into tumor microenvironment, mutation patterns, and personalized treatment strategies

Abstract Background Ovarian cancer (OC) is often associated with an unfavorable prognosis. Given the crucial involvement of lysosomes in tumor advancement, lysosome-related genes (LRGs) hold promise as potential therapeutic targets. Methods To identify differentially expressed lysosome-related genes...

Full description

Saved in:
Bibliographic Details
Main Authors: Ran Sun, Siyi Li, Wanlu Ye, Yanming Lu
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-024-03586-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850100534789275648
author Ran Sun
Siyi Li
Wanlu Ye
Yanming Lu
author_facet Ran Sun
Siyi Li
Wanlu Ye
Yanming Lu
author_sort Ran Sun
collection DOAJ
description Abstract Background Ovarian cancer (OC) is often associated with an unfavorable prognosis. Given the crucial involvement of lysosomes in tumor advancement, lysosome-related genes (LRGs) hold promise as potential therapeutic targets. Methods To identify differentially expressed lysosome-related genes (DE-LRGs), we performed a matching analysis between differentially expressed genes (DEGs) in OC and the pool of LRGs. Genes with prognostic significance were analyzed using multiple regression analyses to construct a prognostic risk signature. The model's efficacy was validated through survival analysis in various cohorts. We further explored the model's correlation with clinical attributes, tumor microenvironment (TME), mutational patterns, and drug sensitivity. The quantitative real-time polymerase chain reaction (qRT-PCR) validated gene expression in OC cells. Results A 10-gene prognostic risk signature was established. Survival analysis confirmed its predictive accuracy across cohorts. The signature served as an independent prognostic element for OC. The high-risk and low-risk groups demonstrated notable disparities in terms of immune infiltration patterns, mutational characteristics, and sensitivity to therapeutic agents. The qRT-PCR results corroborated and validated the findings obtained from the bioinformatic analyses. Conclusions We devised a 10-LRG prognostic model linked to TME, offering insights for tailored OC treatments.
format Article
id doaj-art-98c274f856584a8d8033dc65b359ea3c
institution DOAJ
issn 1475-2867
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj-art-98c274f856584a8d8033dc65b359ea3c2025-08-20T02:40:17ZengBMCCancer Cell International1475-28672024-12-0124112010.1186/s12935-024-03586-wDevelopment of a prognostic model based on lysosome-related genes for ovarian cancer: insights into tumor microenvironment, mutation patterns, and personalized treatment strategiesRan Sun0Siyi Li1Wanlu Ye2Yanming Lu3Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical UniversityDepartment of Obstetrics and Gynecology, Shengjing Hospital of China Medical UniversityDepartment of Obstetrics and Gynecology, Shengjing Hospital of China Medical UniversityDepartment of Obstetrics and Gynecology, Shengjing Hospital of China Medical UniversityAbstract Background Ovarian cancer (OC) is often associated with an unfavorable prognosis. Given the crucial involvement of lysosomes in tumor advancement, lysosome-related genes (LRGs) hold promise as potential therapeutic targets. Methods To identify differentially expressed lysosome-related genes (DE-LRGs), we performed a matching analysis between differentially expressed genes (DEGs) in OC and the pool of LRGs. Genes with prognostic significance were analyzed using multiple regression analyses to construct a prognostic risk signature. The model's efficacy was validated through survival analysis in various cohorts. We further explored the model's correlation with clinical attributes, tumor microenvironment (TME), mutational patterns, and drug sensitivity. The quantitative real-time polymerase chain reaction (qRT-PCR) validated gene expression in OC cells. Results A 10-gene prognostic risk signature was established. Survival analysis confirmed its predictive accuracy across cohorts. The signature served as an independent prognostic element for OC. The high-risk and low-risk groups demonstrated notable disparities in terms of immune infiltration patterns, mutational characteristics, and sensitivity to therapeutic agents. The qRT-PCR results corroborated and validated the findings obtained from the bioinformatic analyses. Conclusions We devised a 10-LRG prognostic model linked to TME, offering insights for tailored OC treatments.https://doi.org/10.1186/s12935-024-03586-wOvarian cancerLysosomePrognosisTumor microenvironmentRisk signatureqRT-PCR
spellingShingle Ran Sun
Siyi Li
Wanlu Ye
Yanming Lu
Development of a prognostic model based on lysosome-related genes for ovarian cancer: insights into tumor microenvironment, mutation patterns, and personalized treatment strategies
Cancer Cell International
Ovarian cancer
Lysosome
Prognosis
Tumor microenvironment
Risk signature
qRT-PCR
title Development of a prognostic model based on lysosome-related genes for ovarian cancer: insights into tumor microenvironment, mutation patterns, and personalized treatment strategies
title_full Development of a prognostic model based on lysosome-related genes for ovarian cancer: insights into tumor microenvironment, mutation patterns, and personalized treatment strategies
title_fullStr Development of a prognostic model based on lysosome-related genes for ovarian cancer: insights into tumor microenvironment, mutation patterns, and personalized treatment strategies
title_full_unstemmed Development of a prognostic model based on lysosome-related genes for ovarian cancer: insights into tumor microenvironment, mutation patterns, and personalized treatment strategies
title_short Development of a prognostic model based on lysosome-related genes for ovarian cancer: insights into tumor microenvironment, mutation patterns, and personalized treatment strategies
title_sort development of a prognostic model based on lysosome related genes for ovarian cancer insights into tumor microenvironment mutation patterns and personalized treatment strategies
topic Ovarian cancer
Lysosome
Prognosis
Tumor microenvironment
Risk signature
qRT-PCR
url https://doi.org/10.1186/s12935-024-03586-w
work_keys_str_mv AT ransun developmentofaprognosticmodelbasedonlysosomerelatedgenesforovariancancerinsightsintotumormicroenvironmentmutationpatternsandpersonalizedtreatmentstrategies
AT siyili developmentofaprognosticmodelbasedonlysosomerelatedgenesforovariancancerinsightsintotumormicroenvironmentmutationpatternsandpersonalizedtreatmentstrategies
AT wanluye developmentofaprognosticmodelbasedonlysosomerelatedgenesforovariancancerinsightsintotumormicroenvironmentmutationpatternsandpersonalizedtreatmentstrategies
AT yanminglu developmentofaprognosticmodelbasedonlysosomerelatedgenesforovariancancerinsightsintotumormicroenvironmentmutationpatternsandpersonalizedtreatmentstrategies